Regulatives Submission Issues [Study As­sess­ment]

posted by balakotu – India, 2014-05-19 16:06 (4424 d 15:28 ago) – Posting: # 12970
Views: 6,250

Dear All,

Please clarify the below query

We conducted fed pivotal BE study. The clinical phase of study is initiated with 36 subjects as per protocol, out of 36 subjects only 17 Subjects completed the analysis. Whether we can submit the BE data with this less number of subjects (N=17 Subjects). Please share your thoughts on regulatory concerns in such cases of high dropouts.

Regards
Kotu.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
293 visitors (0 registered, 293 guests [including 34 identified bots]).
Forum time: 07:35 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5